Bliv Tirzepatide Review: Starting Price & Current Refund Terms

Bliv advertises compounded tirzepatide “as low as $199 per month,” based on plan structure and eligibility. Its separate $29-per-month financing headline is not the medication price. Confirm the full treatment charge, supplied period and financing agreement before comparing offers.³

The headline does not establish your selected total

The pricing section does not give every dose-specific or longer-plan charge. The general “from $58” or semaglutide headline should not be substituted for the named tirzepatide amount. A conditional starting price does not establish which plan you qualify for, the first charge or a guaranteed continuing rate.³

The DudeMeds review shows why the first charge and continuing price need separate questions: its named tirzepatide offer is $149 once for the first 28 days, explicitly introductory rather than an ongoing monthly rate. Confirm the next supplied period and full charge before comparing an introductory offer with a conditional monthly headline.⁵

Bliv markets no long-term commitments or cancellation fees. Its terms, effective October 15, 2026, nevertheless say paid subscriptions renew automatically at the then-current price until canceled. Purchase terms must disclose the charge, frequency and any minimum term. Cancellation takes effect at the end of the paid period; subscription and program fees generally are not refunded or prorated.^3,4

The terms distinguish canceling a subscription from canceling a pending prescription, laboratory order or appointment. Ask for the specific order’s status rather than assuming that stopping future billing stops medication already being prepared.⁴

Evaluation and medication have different refund rules

If the clinician finds you are not a candidate or declines to treat you, the terms promise a full evaluation-fee refund. Once the evaluation is completed and treatment offered, the evaluation fee is generally nonrefundable. That distinction matters even when you decide not to proceed.⁴

Medication is not charged until a prescription is approved. The terms permit a full medication-order refund before prescription transmission to the pharmacy; after transmission, medication is nonrefundable. If the pharmacy cannot fill the prescription, they offer a medication-charge refund or a clinician-approved alternative.⁴

The terms expressly prohibit setup, coordination or processing deductions unless a specific fee was separately disclosed before purchase. They do not establish a universal $200 deduction or fixed $24.99 evaluation charge. Obtain any actual separately stated fee in the selected agreement.⁴

The Options Medical Weight Loss review illustrates why the service and starting event matter: its FAQ gives a 24-hour initial-program refund window and a separate 72-hour policy under a membership agreement. Those are differently described scopes, not a universal medication-return right. Ask which agreement and cutoff apply to the actual purchase before comparing a refund promise with Bliv’s evaluation and prescription-transmission rules.⁶

For damaged, incorrect or unusable shipments, report the problem within seven days for a no-charge replacement under the terms. Approved refunds are issued to the original payment method within ten business days. A replacement policy is different from an unconditional medication refund after transmission.⁴

Identify the platform and treating practice

The terms identify Metabody Services, LLC as the technology/management company, with medical care provided by Metabody Medical P.A. and state-specific affiliated professional entities. These disclosures do not establish your assigned clinician, current credentials or preparing/dispensing pharmacy. Confirm the responsible practice and actual prescription before paying.⁴

Brand-drug trials do not establish outcomes for this platform or a compounded preparation. SURMOUNT-1 and SURMOUNT-5 provide clinical context, not proof that the platform’s advertised results or every formulation will match them.^1,2

Further reading

whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, bmiMD, best tirzepatide providers.